Researchers from the Genome Center have successfully applied advanced artificial intelligence (AI) genetics models to Parkinson's disease. Researchers identified genetic factors in progression and ...

In trials at University College London Hospitals (UCLH), an ASO is being used to target the mutated gene that results in the ...

Base editing utilizes enzymes to modify single amino acids at the most foundational unit of DNA, called a base.

Armed with data from a small phase 1/2 bridging study, MeiraGTx is preparing to take its gene therapy for Parkinson's disease into a pivotal trial. Shares in the Anglo-US biotech rose sharply ...

Berlin, Germany, and Research Triangle Park, N.C., USA, Jan. 14, 2025 (GLOBE NEWSWIRE) -- Not intended for UK MediaEnrollment ongoing in the ...

The US company has said it is launching the Phase III trials in the first half of this year after Phase I talks with the US ...

We can do better. We can build a system that provides coordinated high-quality care to every patient who needs it.

AskBio begins patient randomizing in phase II gene therapy trial for Parkinson’s disease: Berlin, Germany Wednesday, January 15, 2025, 14:00 Hrs [IST] AskBio Inc. (AskBio), a ge ...

14, 2025 — There may be a link between hearing impairment and an increased risk of developing Parkinson's according ... for a given disease against five databases that provide gene-disease ...

AskBio Inc. (AskBio), a gene therapy company wholly owned and ... in its Phase II clinical trial in patients with Parkinson’s disease (PD). “The randomization of the first participants in ...

14, 2025 — There may be a link between hearing impairment and an increased risk of developing Parkinson's according ... for a given disease against five databases that provide gene-disease ...